Comprehensive Financial Planning’s AbbVie ABBV Stock Holding History

Comprehensive Financial Planning’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87.9K	Buy	349 +3	+0.9%	+$645	0.05%	147
2026 Q1	$75.3K	Sell	346 -200	-37%	-$44.4K	0.05%	137
2025 Q4	$125K	Buy	546 +3	+0.6%	+$683	0.08%	116
2025 Q3	$126K	Buy	543 +4	+0.7%	+$815	0.09%	118
2025 Q2	$100K	Buy	539 +204	+61%	+$37.9K	0.08%	126
2025 Q1	$70.3K	Buy	335 +2	+0.6%	+$389	0.07%	119
2024 Q4	$59.1K	Buy	+333	New	+$61.2K	0.05%	149

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Comprehensive Financial Planning's ABBV Position: Q2 2026 in Review

Comprehensive Financial Planning increased its AbbVie (ABBV) stake by 0.87% in Q2 2026, buying an estimated $645 and bringing the position to 349 shares worth $87.9K. The position accounts for 0.05% of the portfolio, ranked #147.

Comprehensive Financial Planning first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $126K in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Comprehensive Financial Planning held 349 shares of AbbVie worth $87.9K as of Q2 2026.
Comprehensive Financial Planning bought 3 AbbVie shares in Q2 2026, an estimated $645.
AbbVie made up 0.05% of Comprehensive Financial Planning's portfolio in Q2 2026, its #147 holding.
Comprehensive Financial Planning first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Comprehensive Financial Planning's AbbVie position peaked at $126K in Q3 2025.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Comprehensive Financial Planning's 13F filing for Q2 2026, filed 10 Aug 2026.